Home » Topics » Disease categories and therapies » Cancer

Cancer
RSS

Angiostatin-AAV reduces tumor burden and increases survival in preclinical trials

June 10, 2002

Irofulven plus Xeloda evaluated in phase I trial in advanced solid tumors

June 10, 2002

Coenzyme A-peptide conjugates for use in cancer

June 10, 2002

Pierre Fabre presents new protein prenyltransferase inhibitors

June 10, 2002

PI-88 plus Taxotere to be evaluated in phase I trial

June 7, 2002

Phase Ib trial evaluating CA4P in combination with carboplatin in advanced solid tumors

June 7, 2002

Phase II dose of orally active MEK inhibitor selected from phase I studies

June 7, 2002

Acceptable safety and PK profile emerges from ongoing phase I trial of EKB-569

June 7, 2002

A phase I trial in patients with advanced solid tumors shows the safety and efficacy of BMS-214662

June 7, 2002

Phase III trial of RSR-13 in brain metastases continues following interim review

June 7, 2002

Popular Stories

Today's news in brief
BioWorld
IL-22 and TL1A, a robust couple for diagnosing hidradenitis suppurativa
BioWorld Science
Hidradenitis suppurativa (HS) is a chronic inflammatory skin disease with strong association with psoriasis and inflammatory bowel disease (IBD). While some...
TL1A is overexpressed in hidradenitis suppurativa
BioWorld Science
Despite the availability of advanced therapeutic options, about 40%-50% of patients with hidradenitis suppurativa do not achieve significant improvement in...
Inhibiting the NLRP3 inflammasome for cognitive impairment, stroke
BioWorld Science
Vascular cognitive impairment and dementia (VCID) and cerebral small vessel disease are among the leading causes of dementia, where inflammation is known to play...
VST Bio’s VB-001 is neuroprotector after stroke
BioWorld Science
At the recent International Stroke Conference, researchers from VST Bio Corp. and Yale University presented preclinical data regarding VB-001, a monoclonal...